SCHEMBL8264266

SCHEMBL8264266

COCCCN1CC(C=O)c2c(F)cccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.38
PARP1 P09874 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SCN9A Q15858 1/20 0.34
REN P00797 4/20 0.34
ALDH1A1 P00352 2/20 0.33
CACNA1G O43497 2/20 0.33
CACNA1H O95180 2/20 0.33
CACNA1I Q9P0X4 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
DRD2 P14416 1/20 0.33
HTR2A P28223 1/20 0.33
HRH1 P35367 1/20 0.33
TYMS P04818 1/20 0.32
ALOX15 P16050 1/20 0.31
GRM4 Q14833 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8261724 0.79 CYP2C9 (0.40) HTTPARP1PARP2CYP2D6CYP2C9
SCHEMBL8265470 0.78 L3MBTL1 (0.37) HTTPARP1PARP2CYP2D6CYP2C9
SCHEMBL8006237 0.75 OPRL1 (0.33) HTTPARP1PARP2CYP2D6CYP2C9
SCHEMBL8264212 0.75 L3MBTL1 (0.35) CYP2D6CYP2C9CYP2C19RENALDH1A1
SCHEMBL8265922 0.70 LMNA (0.38) HTTCYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL8264308 0.68 ALDH1A1 (0.35) CYP2D6CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL14572801 0.66 CYP2D6 (0.43) HTTPARP1PARP2CYP2D6CYP2C9
SCHEMBL7999343 0.64 CYP2D6 (0.32) HTTPARP1PARP2CYP2D6CYP2C9
SCHEMBL16685237 0.64 HTR2C (0.38) CACNA1GCACNA1HCACNA1I
SCHEMBL27668930 0.64 SCN9A (0.34) SCN9AALDH1A1DRD2HTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833816-B1 SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-11-11 EP disclosed
WO-2006069788-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-07-06 WO disclosed